3976 - 4000 of 8818 Results
Title
Year
-
RESTRICTEDTitle: Extent of Inhibition of α-Synuclein Aggregation in Vitro by SUMOylation Is Conjugation Site- and SUMO Isoform-SelectiveJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 959End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi501512mCitation Count: 56
-
OPENTitle: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy ControlsJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 13Issue #: 17Start Page: 1447End Page: 1457Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2019-0315Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2019-0315Citation Count: 35
-
OPENTitle: Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: Towards a harmonized segmentation protocolJournal Name: NeuroImagePublisher: Elsevier BVVol: 111Issue #:Start Page: 526End Page: 541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2015.01.004Citation Count: 343
-
OPENTitle: Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human CortexJournal Name: Brain StimulationPublisher: Elsevier BVVol: 8Issue #: 3Start Page: 481End Page: 485Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2014.12.002Citation Count: 50
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2943649Citation Count: 199
-
OPENTitle: Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI dataJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 656End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.001Best OA location URL: https://doi.org/10.1016/j.nicl.2017.02.001Citation Count: 73
-
OPENTitle: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1632End Page: 1642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27404Citation Count: 15
-
RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 29
-
OPENTitle: Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s DiseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0097-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0097-0Citation Count: 73
-
RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
-
RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 81
-
RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 39
-
OPENTitle: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0426-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0426-8Citation Count: 87
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 55
-
OPENTitle: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluidJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0055-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0055-2Citation Count: 39
-
OPENTitle: Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson’s Disease Treatment: Toward Rapid Semi-Automated Stimulation OptimizationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 589End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3448392Best OA location URL: https://doi.org/10.1109/jtehm.2024.3448392Citation Count: 5
-
OPENTitle: Linear ubiquitination induces NEMO phase separation to activate NF-κB signalingJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 6Issue #: 4Start Page: e202201607End Page: e202201607Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202201607Best OA location URL: https://www.life-science-alliance.org/content/lsa/6/4/e202201607.full.pdfCitation Count: 28
-
OPENTitle: Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluorJournal Name: Current Protocols in Chemical BiologyPublisher: WileyVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpch.45Citation Count: 6
-
RESTRICTEDTitle: The link between mitochondrial complex I and brain-derived neurotrophic factor in SH-SY5Y cells – The potential of JNX1001 as a therapeutic agentJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 764Issue #:Start Page: 379End Page: 384Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2015.07.013Citation Count: 20
-
OPENTitle: Low plasma serotonin linked to higher nigral iron in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-03700-2Best OA location URL: https://www.nature.com/articles/s41598-021-03700-2.pdfCitation Count: 13
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 63
-
OPENTitle: French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease–Rating Scale (QUIP-RS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 117End Page: 123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.026Best OA location URL: http://www.prd-journal.com/article/S1353802019300720/pdfCitation Count: 12
-
RESTRICTEDTitle: Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted ratsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 219Issue #: 1Start Page: 355End Page: 358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.010Citation Count: 46
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 34
-
RESTRICTEDTitle: Clinical and imaging markers in premotor LRRK2 G2019S mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 10Start Page: 1170End Page: 1176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.007Citation Count: 37